PlainRecalls
FDA Drug Critical Class I Terminated

Linezolid Injection 600 mg/300 mL (2 mg/mL), 300 mL Single-use, ready-to-use flexible plastic infusion bags in a foil laminate overwrap, Rx only, Mfd in India for: AuroMedics Pharma LLC, Dayton, NJ --- NDC 55150-242-51

Reported: February 14, 2018 Initiated: December 20, 2017 #D-0337-2018

Product Description

Linezolid Injection 600 mg/300 mL (2 mg/mL), 300 mL Single-use, ready-to-use flexible plastic infusion bags in a foil laminate overwrap, Rx only, Mfd in India for: AuroMedics Pharma LLC, Dayton, NJ --- NDC 55150-242-51

Reason for Recall

Presence of Particulate Matter; white particulate matter identified as mold was found in one bag

Details

Recalling Firm
AuroMedics Pharma LLC
Units Affected
9,050 bags
Distribution
Product was distributed throughout United States.
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Linezolid Injection 600 mg/300 mL (2 mg/mL), 300 mL Single-use, ready-to-use flexible plastic infusion bags in a foil laminate overwrap, Rx only, Mfd in India for: AuroMedics Pharma LLC, Dayton, NJ --- NDC 55150-242-51. Recalled by AuroMedics Pharma LLC. Units affected: 9,050 bags.
Why was this product recalled?
Presence of Particulate Matter; white particulate matter identified as mold was found in one bag
Which agency issued this recall?
This recall was issued by the FDA Drug on February 14, 2018. Severity: Critical. Recall number: D-0337-2018.